MedPath

Prevention of residual neuromuscular blockade with sugammadex in patients received general anesthesia

Not Applicable
Conditions
Diseases which need operation under general anesthesia
Registration Number
JPRN-UMIN000004522
Lead Sponsor
Tokyo Neuromuscular Meeting
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
25
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who have a history of hypersensitivity to rocuronium and bromide. Patients who have a history of hypersensitivity to sugammadex. Patients who have myasthenia gravis and myasthenic syndrome.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath